Herwenda Unione Europea - italiano - EMA (European Medicines Agency)

herwenda

sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - agenti antineoplastici - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).